Generic Name : Imiquimod Pronunciation : im-I-kwi-mod Therapeutic Classification : Miscellaneous Dermatologicals ICD Code : Y56.9
India- Imiquad, Nilwart.
International- Zyclara. Why it is prescribed (Indications) : This medication is an immune response modifier, prescribed for certain types of skin growths (actinic keratoses) or skin cancer (superficial basal cell carcinoma). When it is not to be taken (Contraindications): Hypersensitivity.
Dosage & When it is to be taken : Topical: Apply a thin layer of this cream 2 times per week for 16 weeks. How it should be taken : It comes as a cream to apply topically over the affected area as directed by your physician. Warnings and Precautions :
* Caution should be exercised in patients with history of poor immune system, autoimmune disorder, human papilloma virus (HPV) infection, other types of skin cancer, broken, damaged or inflamed skin, any allergy, who are taking other medications, children, during pregnancy and breastfeeding.
* It may cause dizziness, do not drive a car or operate machinery while taking this medication.
* For external use only; avoid contact with vagina, eyes, nose, mouth, lips.
* Avoid exposure to sunlight. Side Effects :
Application site reaction, upper respiratory tract infection, headache, skin cancer, diarrhea, eczema, back pain, fatigue, abnormal heart rhythm, viral infection, dizziness, vomiting, urinary tract infection, fever, rigors and hair loss.
*Avoid excess dosage. Storage Conditions :
Store it at 4 - 25°C.
Comment & Contribute
Ask an Expert